Healthcare and Pharmaceuticals industry

Global Respiratory Tract Infection Treatment Market Size Share Forecast 2025




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Respiratory tract infection is any infection in the nose, sinuses around the nose, throat (pharynx), voice box (larynx), and windpipe (trachea), airways (bronchi) or lungs, which may occur anytime, usually beginning with cold. This infection is usually caused by bacteria and viruses. Virus prone respiratory tract infection are easily transmitted and very contagious while bacterial infection can also be developed during the course of an upper respiratory tract infection. Respiratory tract infection is generally divided into two categories- upper respiratory tract infection (infection in nose, throat, and pharynx) and lower respiratory tract infection (infection below the larynx).
Market Dynamics
The global respiratory tract infection market is expected to witness lucrative growth due to factors such as increasing prevalence of lung diseases, surge in geriatric population, and rising risk of pneumonia in children. According to the World Health Organization (WHO), respiratory syncytial virus (RSV) is responsible for around 30 million lower respiratory tract infection cases in children worldwide. The prevalence of such viral diseases is expected to drive growth of the global market over the forecast period.
Increasing air pollution can severely affect respiratory health of children as well as adults. Various studies have shown effects of air pollution that can exacerbate existing respiratory conditions such as asthma, COPD, and upper airway allergies.
However, adverse effects of using NSAIDs and antibiotics on patients suffering from respiratory tract infection may hinder growth of the market. In 2015, the U.S. Food and Drug Administration (FDA) increased the warning labels on over-the-counter NSAIDs to highlight elevated risks for heart attack and stroke.
Key features of the study:

This report provides in-depth analysis of the respiratory tract infection treatment market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2018 – 2026), considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global respiratory tract infection treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Abbott Laboratories, AstraZeneca, Plc, Abbvie Inc., Boehringer Ingelheim GmbH, Cipla Pharmaceutical Company, GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Novartis AG, F. Hoffman La Roche Ltd, Sanofi, and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global respiratory tract infection treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for respiratory tract infection treatment market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Respiratory Tract Infection Treatment Market, By Drug Class:

Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others

Global Respiratory Tract Infection Treatment Market, By Disease Indication:

Upper Respiratory Tract Infection
Lower Respiratory Tract Infection

Global Respiratory Tract Infection Treatment Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Respiratory Tract Infection Treatment Market, By Region:

North America

By Country:

U.S.
Canada

By Drug Class:

Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others

By Disease Indication:

Upper Respiratory Tract Infection
Lower Respiratory Tract Infection

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Drug Class:

Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others

By Disease Indication:

Upper Respiratory Tract Infection
Lower Respiratory Tract Infection

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Asia Pacific

By Country:

Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific

By Drug Class:

Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others

By Disease Indication:

Upper Respiratory Tract Infection
Lower Respiratory Tract Infection

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Latin America

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

By Drug Class:

Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others

By Disease Indication:

Upper Respiratory Tract Infection
Lower Respiratory Tract Infection

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Middle East

By Country:

GCC
Israel
Rest of Middle East

By Drug Class:

Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others

By Disease Indication:

Upper Respiratory Tract Infection
Lower Respiratory Tract Infection

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Africa

By Country:

South Africa
Central Africa
North Africa

By Drug Class:

Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others

By Disease Indication:

Upper Respiratory Tract Infection
Lower Respiratory Tract Infection

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies



Company Profiles

Abbott Laboratories*

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

AstraZeneca, Plc
Abbvie Inc.
Boehringer Ingelheim GmbH
Cipla Pharmaceutical Company
GlaxoSmithKline plc
Pfizer Inc.
Merck & Co.
Novartis AG
F. Hoffman La Roche Ltd
Sanofi
Teva Pharmaceutical Industries Ltd.


“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Drug Class
o Market Snippet, By Disease Indication
o Market Snippet, By Distribution Channel
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Regulatory Scenario
o Pipeline Analysis
o Epidemiology
o PEST Analysis
o PORTER'S Analysis
4. Global Respiratory Tract Infection Treatment Market, By Drug Class, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Antibiotics
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Cough Suppressant
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Nasal Decongestant
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
5. Global Respiratory Tract Infection Treatment Market, By Disease Indication, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Upper Respiratory Tract Infection
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Lower Respiratory Tract Infection
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
6. Global Respiratory Tract Infection Treatment Market, By Distribution Channel, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Hospital Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Retail Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Online Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
7. Global Respiratory Tract Infection Treatment Market, By Region, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2016-2026
o Regional Trends
o North America
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o North Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Abbott Laboratories
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o AstraZeneca, Plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Abbvie Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Boehringer Ingelheim GmbH
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Cipla Pharmaceutical Company
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o GlaxoSmithKline Plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Merck & Co.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Novartis AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o F. Hoffman La Roche Ltd
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Teva Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Sanofi
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 25 market data tables and 22 figures on "Respiratory Tract Infection Treatment Market" - Global forecast to 2026".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.